Cytokine profiles in sepsis have limited relevance for stratifying patients in the emergency department: A prospective observational study

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Lvovschi, Virginie ^a,b   Arnaud, Laurent ^a,b   Parizot, Christophe ^a   Freund, Yonathan ^a,c   Juillien, Gaëlle ^a   Ghillani Dalbin, Pascale ^a   Bouberima, Mohammed ^a   Larsen, Martin ^a,b,c   Riou, Bruno ^a,b,c   Gorochov, Guy ^a,b,c   Hausfater, Pierre ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CXCL9 CHEMOKINE; CYTOKINE; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; FEVER; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALARIA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PATIENT CODING; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUBERCULOSIS; UNIVARIATE ANALYSIS; VIRUS INFECTION; BLOOD; EMERGENCY HEALTH SERVICE; FRANCE; MICROBIOLOGY; MIDDLE AGED; MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; CYTOKINES; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER; FRANCE; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84855287677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028870     Document Type: Article

References (32)

1. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
2. Heffner AC, Horton JM, Marchick MR, Jones AE, (2010) Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 50: 814-820.
3. Aalto H, Takala A, Kautiainen H, Repo H, (2004) Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 23: 699-704.
4. Heper Y, Akalin EH, Mistik R, Akgoz S, Tore O, et al. (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25: 481-491.
5. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, et al. (2000) Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28 (8): 2793-2798.
6. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, et al. (2007) Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 11: R49.
7. Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, et al. (2002) Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 30: 757-762.
8. Damas P, Canivet JL, de Groote D, Vrindts Y, Albert A, et al. (1997) Sepsis and serum cytokine concentrations. Crit Care Med 25 (3): 405-412.
9. De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler E, Cardier JE, (2004) Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 125: 2238-2246.
10. Dinarello CA, (1997) Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S-329S.
11. Gogos CA, Drosou E, Bassaris HP, Skoutelis A, (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176-180.
12. Hausfater P, Garric S, Ayed SB, Rosenheim M, Bernard M, et al. (2002) Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 34: 895-901.
13. Hausfater P, Juillien G, Madonna-Py B, Haroche J, Bernard M, et al. (2007) Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 11: R60.
14. Kofoed K, Schneider UV, Scheel T, Andersen O, Eugen-Olsen J, (2006) Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clin Chem 52: 1284-1293.
15. Reinhart K, Karzai W, Meisner M, (2000) Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 26: 1193-1200.
16. Ulloa L, Tracey KJ, (2005) The "cytokine profile": a code for sepsis. Trends Mol Med 11: 56-63.
17. Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, et al. (2010) Multiplex cytokine profiling in patients with sepsis. APMIS 119: 155-163.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
19. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, et al. (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31: 670-675.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (1992) Crit Care Med 20: 864-874.
21. Ward J, (1963) Hierarchical grouping to optimize an objective function. J Am Stat Assoc 58: 236-244.
22. Casey LC, Balk RA, Bone RC, (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771-778.
23. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, et al. (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103: 565-575.
24. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M, (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950-953.
25. Vermont CL, Hazelzet JA, de Kleijn ED, van den Dobbelsteen GP, de Groot R, (2006) CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity. Crit Care 10: R33.
26. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, et al. (2005) Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23: 488-493.
27. Wang H, Liao H, Ochani M, Justiniani M, Lin X, et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10: 1216-1221.
28. Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, et al. (2010) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36: 621-629.
29. Calandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, et al. (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis 161: 982-987.
30. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP, (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 91: 23-29.
31. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481-1486.
32. Feezor RJ, Oberholzer C, Baker HV, Novick D, Rubinstein M, et al. (2003) Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 71: 5803-5813.